{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:54:01Z","timestamp":1772517241872,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017268","name":"Berlin Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A patient with gastrointestinal stroma tumor (GIST) and KIT p.V559D and BRAF p.G469A alterations was referred to our institutional molecular tumor board (MTB) to discuss therapeutic implications. The patient had been diagnosed with B-cell chronic lymphocytic leukemia (CLL) years prior to the MTB presentation. GIST had been diagnosed 1 month earlier. After structured clinical annotation of the molecular alterations and interdisciplinary discussion, we considered BRAF\/KIT co-mutation unlikely in a treatment-na\u00efve GIST. Discordant variant allele frequencies furthermore suggested a second malignancy. NGS of a CLL sample revealed the identical class 2 BRAF alteration, thus supporting admixture of CLL cells in the paragastric mass, leading to the detection of 2 alterations. Following the MTB recommendation, the patient received imatinib and had a radiographic response. Structured annotation and interdisciplinary discussion in specialized tumor boards facilitate the clinical management of complex molecular findings. Coexisting malignancies and clonal hematopoiesis warrant consideration in case of complex and uncommon molecular findings.<\/jats:p>","DOI":"10.1093\/oncolo\/oyae137","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T02:03:10Z","timestamp":1718676190000},"page":"908-912","source":"Crossref","is-referenced-by-count":1,"title":["A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3976-9592","authenticated-orcid":false,"given":"Stefan","family":"Habringer","sequence":"first","affiliation":[{"name":"Campus Benjamin Franklin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin Department of Hematology, Oncology and Cancer Immunology, , Berlin 12203 ,","place":["Germany"]},{"name":"German Cancer Consortium (DKTK) , Berlin 10115 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-1321","authenticated-orcid":false,"given":"Jana","family":"Ihlow","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health (BIH), Charit\u00e9 - Universit\u00e4tsmedizin Berlin , Berlin 10178 ,","place":["Germany"]},{"name":"Institute of Pathology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9136-6902","authenticated-orcid":false,"given":"Karsten","family":"Kleo","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Klostermann","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidan","family":"Chai","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"Kn\u00f6dler","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-6799","authenticated-orcid":false,"given":"Serge","family":"Leyvraz","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Sigler","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1257-9799","authenticated-orcid":false,"given":"Bruno","family":"Sinn","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-2466","authenticated-orcid":false,"given":"Georg","family":"Maschmeyer","sequence":"additional","affiliation":[{"name":"Campus Benjamin Franklin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin Department of Hematology, Oncology and Cancer Immunology, , Berlin 12203 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette","family":"Jegodka","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3067-2030","authenticated-orcid":false,"given":"Manuela","family":"Benary","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health (BIH), Charit\u00e9 - Universit\u00e4tsmedizin Berlin , Berlin 10178 ,","place":["Germany"]},{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3627-3791","authenticated-orcid":false,"given":"Claus-Eric","family":"Ott","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Medizinische Genetik und Humangenetik, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 13353 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-549X","authenticated-orcid":false,"given":"Ingeborg","family":"Tinhofer","sequence":"additional","affiliation":[{"name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin Department of Radiooncology and Radiotherapy, , Berlin 10115 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-2124","authenticated-orcid":false,"given":"Reinhold","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-3032","authenticated-orcid":false,"given":"Markus","family":"M\u00f6bs","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8485-1958","authenticated-orcid":false,"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[{"name":"Campus Benjamin Franklin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin Department of Hematology, Oncology and Cancer Immunology, , Berlin 12203 ,","place":["Germany"]},{"name":"German Cancer Consortium (DKTK) , Berlin 10115 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-9406","authenticated-orcid":false,"given":"Ulrich","family":"Keilholz","sequence":"additional","affiliation":[{"name":"German Cancer Consortium (DKTK) , Berlin 10115 ,","place":["Germany"]},{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0027-7977","authenticated-orcid":false,"given":"Damian T","family":"Rieke","sequence":"additional","affiliation":[{"name":"Campus Benjamin Franklin, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin Department of Hematology, Oncology and Cancer Immunology, , Berlin 12203 ,","place":["Germany"]},{"name":"German Cancer Consortium (DKTK) , Berlin 10115 ,","place":["Germany"]},{"name":"Charit\u00e9 Comprehensive Cancer Center, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin 10117 ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"2024100317293993300_CIT0001","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2019.12.017","article-title":"Support of a molecular tumour board by an evidence-based decision management system for precision oncology","volume":"127","author":"Lamping","year":"2020","journal-title":"Eur J Cancer"},{"issue":"5350","key":"2024100317293993300_CIT0002","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science (New York, N.Y.)."},{"issue":"3","key":"2024100317293993300_CIT0003","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2559.2008.02977.x","article-title":"Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours","volume":"53","author":"Lasota","year":"2008","journal-title":"Histopathology"},{"issue":"10","key":"2024100317293993300_CIT0004","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/gcc.20589","article-title":"Novel V600E BRAF mutations in Imatinib-naive and Imatinib-resistant gastrointestinal stromal tumors","volume":"47","author":"Agaram","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"2024100317293993300_CIT0005","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/gcc.23182","article-title":"BRAF mutations and concurrent alterations in patients with soft tissue sarcoma","volume":"62","author":"Kobayashi","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2024100317293993300_CIT0006","doi-asserted-by":"crossref","first-page":"a005934","DOI":"10.1101\/mcs.a005934","article-title":"Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21)","volume":"7","author":"Burlet","year":"2021","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"3","key":"2024100317293993300_CIT0007","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3324\/haematol.2018.196931","article-title":"Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia","volume":"104","author":"Gim\u00e9nez","year":"2019","journal-title":"Haematologica"},{"issue":"6","key":"2024100317293993300_CIT0008","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3109\/10428194.2012.742525","article-title":"BRAF mutations in chronic lymphocytic leukemia","volume":"54","author":"Jebaraj","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"2024100317293993300_CIT0009","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamaoncol.2016.6728","article-title":"Correlation of long-term results of Imatinib in advanced gastrointestinal stromal tumors with next-generation sequencing Results: analysis of phase 3 SWOG intergroup trial S0033","volume":"3","author":"Heinrich","year":"2017","journal-title":"JAMA Oncol."},{"issue":"6","key":"2024100317293993300_CIT0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.2017.75.3780","article-title":"Targeted therapy for advanced solid tumors on the basis of molecular profiles: results from mypathway, an open-label, phase IIA multiple basket study","volume":"36","author":"Hainsworth","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"2024100317293993300_CIT0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.annonc.2019.10.022","article-title":"Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations","volume":"31","author":"Mazieres","year":"2020","journal-title":"Ann Oncol"},{"issue":"10","key":"2024100317293993300_CIT0012","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1016\/j.jtho.2020.07.007","article-title":"Durable response to dabrafenib combined with trametinib in a patient with NSCLC harboring a BRAF G469A mutation","volume":"15","author":"Dagogo-Jack","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"8","key":"2024100317293993300_CIT0013","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1158\/1078-0432.CCR-19-3443","article-title":"Trametinib activity in patients with solid tumors and lymphomas harboring BRAF non-V600 mutations or fusions: results from NCI-MATCH (EAY131)","volume":"26","author":"Johnson","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2024100317293993300_CIT0014","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1158\/1078-0432.CCR-11-2230","article-title":"KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors","volume":"18","author":"Miranda","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2024100317293993300_CIT0015","doi-asserted-by":"crossref","first-page":"153171","DOI":"10.1016\/j.prp.2020.153171","article-title":"BRAF mutations in KIT\/PDGFRA positive gastrointestinal stromal tumours (GISTs): Is their frequency underestimated","volume":"216","author":"Ja\u0161ek","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"11","key":"2024100317293993300_CIT0016","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jamaoncol.2018.2297","article-title":"Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors","volume":"4","author":"Ptashkin","year":"2018","journal-title":"JAMA Oncol"},{"key":"2024100317293993300_CIT0017","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3389\/fonc.2020.00894","article-title":"Resistance-associated mutations in chronic lymphocytic leukemia patients treated with novel agents","volume":"10","author":"Sedlarikova","year":"2020","journal-title":"Front Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/10\/908\/59558371\/oyae137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/29\/10\/908\/59558371\/oyae137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T17:35:03Z","timestamp":1727976903000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/29\/10\/908\/7695340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":17,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,6,17]]},"published-print":{"date-parts":[[2024,10,3]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyae137","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,6,17]]}}}